Unimproved chest pain in patients with minimal or no coronary disease: A behavioral phenomenon

https://doi.org/10.1016/0002-8703(84)90546-5Get rights and content

Abstract

Patients with chest pain and minimal or no coronary disease have a good prognosis for survival, yet many continue to have pain. In our experience with 821 medically treated patients there were three cardiac deaths (0.3%) and two nonfatal myocardial infarctions (0.2%) in the first year after angiography, which had revealed insignificant (<75% narrowing of the luminal diameter) or no coronary artery stenosis. In a subset of 548 patients selected with no apparent systematic difference from the inception cohort of 821 patients, there was complete absence of chest pain in 178 (33%) patients but 155 (28%) had similar or worse pain. From an analysis of clinical history and catheterization data entered in a stepwise logistic regression function, unimproved chest pain was significantly associated with female sex (p = 0.01) and an index of five chest pain descriptors (p = 0.0005). After adding selected behavioral variables available for a representative sample of 217 patients, a high hypochondriasis score (scale I from the Minnesota Multiphasic Personality Inventory) became the strongest determinant of continued pain (p < 0.0001). In our experience, an exaggerated preoccupation with personal health is prospectively associated with continued chest pain in patients with minimal or no coronary disease.

Cited by (112)

  • Prognostic value of an abnormal response to acetylcholine in patients with angina and non-obstructive coronary artery disease: Long-term follow-up of the Heart Quest cohort

    2016, International Journal of Cardiology
    Citation Excerpt :

    Although a majority of patients was asymptomatic at last follow-up, our study also documents that a relevant proportion of patients has persisting symptoms. It is a well-known phenomenon that patients with small vessel or vasospastic disease have long-lasting symptoms despite treatment [4–21]. Thus, these patients are at risk that their symptoms are sometimes disregarded.

  • Cardiac Syndrome X: Update

    2016, Heart Failure Clinics
    Citation Excerpt :

    Studies have shown that certain behavioral characteristics such as hypochondriasis, anxiety, and panic disorders are common in patients with CSX. Wielgosz and colleagues54 found that among 217 patients, a high hypochondriasis score (assessed by the Minnesota Multiphasic Personality Inventory) was the strongest determinant of continued pain in patients with no coronary artery stenosis. In women experiencing chest pain, a history of anxiety disorders is associated with a lower probability of CAD on angiography.55

  • Cardiac Syndrome X: Update 2014

    2014, Cardiology Clinics
  • Anxiety and hypervigilance to cardiopulmonary sensations in non-cardiac chest pain patients with and without psychiatric disorders

    2010, Behaviour Research and Therapy
    Citation Excerpt :

    In addition, our results showed that the impact of cardiac anxiety on pain was fully mediated by interoceptive fear. Considerable research has shown that the syndrome of NCCP can be persistent in some patients (Potts & Bass, 1993; Wielgosz et al., 1984), and our data suggest that conscious attention to body sensations, particularly those sensations that are perceived as threatening or fearful (i.e., cardiopulmonary sensations), is associated with increased chest pain and impairment. Our findings are consistent with research conducted in the laboratory showing that conscious attention is associated with increased pain (Arntz, Dreessen, & Merckelbach, 1991) – however, the influence of body vigilance on chest pain was partly diminished after accounting for the mediating effect of interoceptive fear.

View all citing articles on Scopus
1

This work was supported by Grant HS 03834 from the National Center for Health Services Research and the National Center for Health Care Technology, Hyattsville, Md.; by Research Grants HL-17670 and HL-22740 from the National Heart, Lung and Blood Institute, Bethesda, Md.; by Training Grant LM 07003 and Grant LM 03373 from the National Library of Medicine, Bethesda, Md.; by grants from the Prudential Insurance Company of America, Newark, N.J.; by the Kaiser Family Foundation, Palo Alto, Calif.; by the Andrew W. Mellon Foundation, New York, N.Y.; and by a Canadian Heart Foundation Research Fellowship (Dr. Wielgosz).

View full text